DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Hurvitz SA, Andre F, Jiang Z et al.
Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+ advanced breast cancer: BOLERO-1.
San Antonio Breast Cancer Symposium; 2014 S6-01
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.